STOCK TITAN

Afya Limited Announces Entering Into a Share Purchase Agreement for the Acquisition of Faculdade Única de Contagem

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)

Afya (Nasdaq: AFYA; B3: A2FY34) has entered into a share purchase agreement to acquire 100% of Faculdade Única de Contagem (FUNIC) through its subsidiary Afya Participações S.A. The acquisition adds 60 medical school seats in Contagem, Minas Gerais, marking Afya's fifth medical school in the state. The total purchase price is R$ 100 million, with R$ 60 million paid in cash at closing and R$ 40 million in three annual CDI-adjusted installments.

The deal includes potential for 60 additional seats if approved by MEC within 36 months, with R$ 1 million payment per granted seat. At full maturity in 2030, Afya expects an EV/EBITDA of 3.3x with projected Net Revenues of R$ 52.4 million from Medicine operations.

Afya (Nasdaq: AFYA; B3: A2FY34) ha stipulato un accordo per l'acquisto di azioni per acquisire il 100% della Faculdade Única de Contagem (FUNIC) attraverso la sua controllata Afya Participações S.A. L'acquisizione aggiunge 60 posti di scuola di medicina a Contagem, Minas Gerais, rappresentando la quinta scuola di medicina di Afya nello stato. Il prezzo totale di acquisto è di 100 milioni di R$, con 60 milioni di R$ pagati in contante al momento della chiusura e 40 milioni di R$ in tre rate annuali aggiustate al CDI.

L'accordo prevede la possibilità di 60 posti aggiuntivi se approvati dal MEC entro 36 mesi, con un pagamento di 1 milione di R$ per ogni posto concesso. Al pieno raggiungimento nel 2030, Afya prevede un EV/EBITDA di 3,3x con ricavi netti previsti di 52,4 milioni di R$ dalle operazioni di Medicina.

Afya (Nasdaq: AFYA; B3: A2FY34) ha entrado en un acuerdo de compra de acciones para adquirir el 100% de Faculdade Única de Contagem (FUNIC) a través de su subsidiaria Afya Participações S.A. La adquisición añade 60 plazas en la escuela de medicina en Contagem, Minas Gerais, siendo la quinta escuela de medicina de Afya en el estado. El precio total de compra es de 100 millones de R$, con 60 millones de R$ pagados en efectivo al cierre y 40 millones de R$ en tres cuotas anuales ajustadas por CDI.

El acuerdo incluye la posibilidad de 60 plazas adicionales si son aprobadas por el MEC en un plazo de 36 meses, con un pago de 1 millón de R$ por cada plaza concedida. A plena madurez en 2030, Afya espera un EV/EBITDA de 3,3x con ingresos netos proyectados de 52,4 millones de R$ de las operaciones de Medicina.

Afya (Nasdaq: AFYA; B3: A2FY34)는 자회사 Afya Participações S.A.를 통해 Faculdade Única de Contagem (FUNIC)의 100%를 인수하는 주식 매매 계약을 체결했습니다. 이번 인수는 미나스 제라이스 주의 콘탐겐에서 60개의 의대 자리를 추가하며, Afya의 주 내 다섯 번째 의대가 됩니다. 총 인수가는 1억 레알이며, 6천만 레알이 계약 체결 시 현금으로 지급되고 4천만 레알은 3년 동안 CDI 조정으로 지급됩니다.

이번 거래에는 MEC의 승인을 받을 경우 60개의 추가 자리를 확보할 가능성이 있으며, 승인된 자리마다 100만 레알의 지급이 필요합니다. 2030년 완전 성숙기에는 Afya가 3.3배의 EV/EBITDA를 기대하며, 의학 분야에서 5,240만 레알의 순수익을 예상하고 있습니다.

Afya (Nasdaq: AFYA; B3: A2FY34) a conclu un accord d'achat d'actions pour acquérir 100 % de la Faculdade Única de Contagem (FUNIC) par l'intermédiaire de sa filiale Afya Participações S.A. Cette acquisition ajoute 60 places en école de médecine à Contagem, Minas Gerais, marquant la cinquième école de médecine d'Afya dans l'État. Le prix total d'achat est de 100 millions de R$, avec 60 millions de R$ payés en espèces à la clôture et 40 millions de R$ en trois versements annuels ajustés au CDI.

L'accord comprend la possibilité de 60 places supplémentaires si approuvées par le MEC dans un délai de 36 mois, avec un paiement de 1 million de R$ par place attribuée. À pleine maturité en 2030, Afya s'attend à un EV/EBITDA de 3,3x avec des revenus nets projetés de 52,4 millions de R$ provenant des opérations médicales.

Afya (Nasdaq: AFYA; B3: A2FY34) hat eine Aktienkaufvereinbarung unterzeichnet, um 100% der Faculdade Única de Contagem (FUNIC) über ihre Tochtergesellschaft Afya Participações S.A. zu erwerben. Die Akquisition fügt 60 Studienplätze für Medizinstudenten in Contagem, Minas Gerais, hinzu und stellt Afyas fünfte medizinische Fakultät im Bundesstaat dar. Der Gesamtkaufpreis beträgt 100 Millionen R$, wobei 60 Millionen R$ bei Abschluss in bar gezahlt werden und 40 Millionen R$ in drei jährlichen, an den CDI angepassten Raten gezahlt werden.

Das Geschäft beinhaltet die Möglichkeit für 60 zusätzliche Studienplätze, wenn sie innerhalb von 36 Monaten vom MEC genehmigt werden, mit einer Zahlung von 1 Million R$ pro genehmigten Platz. Bei voller Auslastung im Jahr 2030 erwartet Afya ein EV/EBITDA von 3,3x mit prognostizierten Nettoumsätzen von 52,4 Millionen R$ aus den Medizinbetrieben.

Positive
  • Acquisition adds 60 medical school seats in strategic location
  • Potential for 60 additional seats with MEC approval
  • Expected Net Revenues of R$ 52.4 million at full maturity
  • Attractive EV/EBITDA multiple of 3.3x post synergies
  • Strategic expansion in Minas Gerais market
Negative
  • Significant initial cash outlay of R$ 60 million required
  • Additional debt burden with R$ 40 million in installments
  • Pre-operational status indicates delayed revenue generation
  • Contingent payment of up to R$ 60 million for additional seats

Insights

This acquisition represents a strategic expansion of Afya's medical education footprint in Brazil. The R$100 million purchase with structured payment terms (R$60 million upfront, R$40 million in installments) demonstrates prudent capital allocation. The deal's 3.3x EV/EBITDA multiple at maturity is notably attractive compared to industry standards, suggesting strong value creation potential. The projected R$52.4 million in Net Revenues by 2030 from medical education indicates a healthy ~52% ROI. The potential for 60 additional seats at R$1 million per seat represents significant upside optionality worth up to R$60 million. Think of this as buying a premium location with built-in expansion rights - you pay for current capacity but get first dibs on future growth. The deal's structure, combining immediate operational assets with growth options, effectively balances current value with future potential. The location in Contagem, part of Belo Horizonte's metropolitan area, targets a wealthy demographic hub, promising strong student demand and pricing power.

The acquisition of FUNIC strengthens Afya's dominance in Brazil's medical education market, particularly in the strategic Minas Gerais region. The pre-operational status of the facility, while requiring initial setup investment, allows Afya to implement its proven operational model from day one without having to overcome established practices. The immediate addition of 60 medical seats in a metropolitan area is particularly valuable given Brazil's strict regulations on new medical school approvals. The potential for 60 additional seats represents a rare growth opportunity in a supply-constrained market. The facility's positioning as an academic hub for other medical campuses creates operational synergies and knowledge-sharing opportunities across Afya's network. For context, medical seats in Brazil are like golden tickets - they're strictly regulated and highly profitable, with consistent demand due to the country's chronic shortage of doctors. This acquisition essentially secures a new pipeline of medical professionals in a key economic region.

NOVA LIMA, Brazil--(BUSINESS WIRE)-- Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, announced today that it has entered into a share purchase agreement for the acquisition, through its wholly-owned subsidiary Afya Participações S.A., of 100% of the total share capital of Faculdade Masterclass Ltda. (“Faculdade Única de Contagem” or “FUNIC”), present in Contagem (MG).

The acquisition will add 60 medical school seats to Afya in Contagem, a city in the metropolitan area of Belo Horizonte, the capital of Minas Gerais. FUNIC is pre-operational, with leased real estate prepared for the start of the medical school operation. It will be Afya’s fifth medical school in Minas Gerais and will serve as an academic hub for the other medical campuses in the state. Afya will confirm the expected timing of the first intake, contingent on the completion date of the closing process.

The aggregate purchase price is R$ 100 million, and the Net Debt will be deducted at closing. The price and payment conditions are R$ 60 million will be paid in cash at the closing date, and R$ 40 million will be paid in three annual installments adjusted by the Brazilian interbank interest rates (“CDI”).

Furthermore, there is a potential for 60 additional seats. If approved by the Ministry of Education (“MEC”) within 36 months from the closing date, it will result in an additional payment of R$ 1 million per granted seat, limited to 60 seats.

Afya expects an EV/EBITDA of 3.3x at full maturity and post synergies in 2030 with expected Net Revenues of R$ 52.4 million, of which 100% will come from Medicine.

The transaction's closing is subject to customary and usual conditions, including approval from antitrust regulators.

For more information, please visit https://ir.afya.com.br/news-events/presentations/

About Afya Limited (Nasdaq: AFYA, B3: A2FY34)

Afya is a leading medical education group in Brazil based on the number of medical school seats, delivering an end-to-end physician-centric ecosystem that serves and empowers students and physicians to transform their ambitions into rewarding lifelong experiences from the moment they join us as medical students through their medical residency preparation, graduation program, continuing medical education activities and offering medical practice solutions to help doctors enhance their healthcare services through their whole career.

Investor Relations Contact:

Afya Limited

ir@afya.com.br

Source: Afya Limited

FAQ

What is the total acquisition cost for AFYA's purchase of Faculdade Única de Contagem?

The total acquisition cost is R$ 100 million, with R$ 60 million paid in cash at closing and R$ 40 million in three annual CDI-adjusted installments.

How many medical seats will AFYA gain from the FUNIC acquisition?

AFYA will initially gain 60 medical school seats, with potential for 60 additional seats subject to Ministry of Education approval within 36 months.

What are the expected financial returns from AFYA's FUNIC acquisition?

At full maturity in 2030, AFYA expects an EV/EBITDA of 3.3x post synergies with projected Net Revenues of R$ 52.4 million.

How will AFYA pay for the FUNIC acquisition?

AFYA will pay R$ 60 million in cash at closing and R$ 40 million in three annual installments adjusted by CDI rates.

What is the additional payment structure for extra seats in the FUNIC acquisition?

AFYA will pay R$ 1 million per additional seat granted by MEC within 36 months, to 60 seats, potentially totaling R$ 60 million.

Afya Limited

NASDAQ:AFYA

AFYA Rankings

AFYA Latest News

AFYA Stock Data

1.38B
13.68M
84.14%
23.06%
1.09%
Education & Training Services
Consumer Defensive
Link
United States of America
Nova Lima